Gene therapy compositions and methods for treating parkinson's disease
US2019046506A1
Use of 5ht2a inverse agonists for treating psychosis
WO2018148737A1
5-ht2a serotonin receptor serotonin receptor inverse agonists useful for the prophylaxis and treatment of parkinsonian symptoms associated with a neurodegenerative disease
WO2018102824A1
Methods for treating neurodegenerative disease
US2018042922A1
Compositions and methods of treating a neurodegenerative disease
WO2017147601A1
Methods of improving balance, gait or both in patients with neurological disease
BR112018000728A2
method for the prophylaxis and / or treatment of visual hallucinations in a subject in need
MX2017016413A
Diaryl and arylheteroaryl urea derivatives useful for the prophylaxis and treatment of rem sleep behavior disorder.
EP3291815A1
Methods of treating a neurodegenerative disease
EP3623371A1
Geminal substituted quinuclidine amide compounds as agonists of alpha-7 nicotinic acetylcholine receptors
